Koninklijke Philips (NYSE:PHG) Upgraded by UBS Group to Neutral

UBS Group upgraded shares of Koninklijke Philips (NYSE:PHG) from a sell rating to a neutral rating in a research note issued to investors on Tuesday morning, Marketbeat.com reports.

A number of other equities analysts have also issued reports on the stock. BNP Paribas lowered shares of Koninklijke Philips from an outperform rating to an underperform rating in a research report on Wednesday, February 7th. JPMorgan Chase & Co. raised Koninklijke Philips from an underweight rating to a neutral rating in a report on Tuesday. Finally, StockNews.com raised Koninklijke Philips from a buy rating to a strong-buy rating in a research note on Thursday, February 8th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average target price of $19.00.

Koninklijke Philips Stock Performance

Koninklijke Philips stock opened at $26.82 on Tuesday. Koninklijke Philips has a 12-month low of $17.75 and a 12-month high of $29.44. The stock has a 50-day simple moving average of $20.95 and a 200 day simple moving average of $21.12. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $24.91 billion, a price-to-earnings ratio of -27.94, a P/E/G ratio of 1.39 and a beta of 0.75.

Institutional Investors Weigh In On Koninklijke Philips

A number of institutional investors and hedge funds have recently modified their holdings of the business. Capital Analysts LLC grew its holdings in Koninklijke Philips by 6.3% during the 4th quarter. Capital Analysts LLC now owns 8,820 shares of the technology company’s stock worth $206,000 after acquiring an additional 521 shares during the period. Dorsey & Whitney Trust CO LLC increased its holdings in Koninklijke Philips by 5.7% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 11,374 shares of the technology company’s stock valued at $265,000 after purchasing an additional 615 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in Koninklijke Philips by 3.2% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 22,616 shares of the technology company’s stock valued at $451,000 after buying an additional 696 shares during the period. Kovitz Investment Group Partners LLC boosted its holdings in Koninklijke Philips by 1.7% during the third quarter. Kovitz Investment Group Partners LLC now owns 44,746 shares of the technology company’s stock worth $892,000 after buying an additional 750 shares during the last quarter. Finally, Fifth Third Bancorp grew its position in shares of Koninklijke Philips by 34.4% during the 1st quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after buying an additional 770 shares during the period. 13.67% of the stock is owned by institutional investors.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.